Guggenheim CurrencyShares® Exchange Traded Products

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Guggenheim CurrencyShares® Exchange Traded Products Declare Monthly Distributions

NEW YORK, Feb. 01, 2016 (GLOBE NEWSWIRE) -- Guggenheim Investments, the investment management division of Guggenheim Partners, today announced the distribution declarations for CurrencyShares ® Australian Dollar Trust (NYSE: FXA ).

NYSE Ticker Fund Name Declaration Date Ex- dividend Date Record Date Payable Date/Share   Distribution
FXA CurrencyShares Australian Dollar Trust 1.29.2016 2.1.2016 2.3.2016 2.8.2016 $ 0.07683  
                 

Distributions are made to shareholders on a pro-rata basis (in accordance with the number of shares that are owned) only in the event that the interest earned by the Trust exceeds the sum of the sponsor’s fee for the prior month plus other Trust expenses, if any. There is no guarantee that distributions will be made on a monthly basis.

CurrencyShares ® offer investors and institutions a convenient and cost-effective method of gaining investment benefits similar to that of holding foreign currencies, including potential diversification and hedging benefits. More details about the products are available at www.currencyshares.com .

About Guggenheim Investments

Guggenheim Investments is the global asset management and investment advisory division of Guggenheim Partners, with $198 billion 1 in total assets across fixed income, equity, and alternative strategies. We focus on the return and risk needs of insurance companies, corporate and public pension funds, sovereign wealth funds, endowments and foundations, consultants, wealth managers, and high-net-worth investors. Our 275+ investment professionals perform rigorous research to understand market trends and identify undervalued opportunities in areas that are often complex and underfollowed. This approach to investment management has enabled us to deliver innovative strategies providing diversification opportunities and attractive long-term results.

Diversification neither assures a profit nor eliminates the risk of experiencing investment losses.

CurrencyShares are subject to risks similar to those of stocks and may not be suitable for all investors. The value of the shares of each CurrencyShares Trust relates directly to the value of the foreign currency held by the particular Trust. This creates a concentration risk associated with fluctuations in the price of the applicable foreign currency. Accordingly, a decline in the price of that currency will have an adverse effect on the value of the shares of the particular CurrencyShares Trust. Factors that may have the effect of causing a decline in the price of a foreign currency include national debt levels and trade deficits, domestic and foreign interest rates, investment and trading activities of institutions and global or regional political, economic or financial events and situations. Investors should consider the investment objectives, risks, charges and expenses of these products carefully before investing. The prospectus pertaining to each product contains this and other information about the product. Please read the applicable prospectus, including the Risk Factors section, carefully before you invest. Shares can be bought and sold through a broker and the purchasers or sellers may have to pay brokerage commissions in connection with the transaction. Investment returns and principal value will fluctuate so that shares may be worth more or less than original cost. Shares may only be redeemed directly from the Trust by Authorized Participants via baskets (as defined in the prospectus). There can be no assurance that an active trading market for the shares will develop or be maintained. The CurrencyShares Trusts are not investment companies registered under the Investment Company Act of 1940. As a result the Trust(s) are not subject to the regulatory requirements of investment companies.

The CurrencyShares® Australian Dollar Trust , CurrencyShares® British Pound Sterling Trust , CurrencyShares® Canadian Dollar Trust , CurrencyShares® Chinese Renminbi Trust , CurrencyShares® Euro Trust , CurrencyShares® Japanese Yen Trust , CurrencyShares® Singapore Dollar Trust ,   CurrencyShares® Swiss Franc Trust and CurrencyShares® Swedish Krona Trust (each a “Trust” and collectively, the “Trusts”) has filed a registration statement (including a prospectus) with the SEC for the offerings to which this communication relates. Before you invest in the shares of a Trust, you should read the prospectus in the registration statement and other documents the Trust has filed with the SEC for more complete information about the Trust and its offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov . Alternatively, you may click the links above or the Trust will arrange to send you its prospectus if you request it by calling toll-free 800.820.0888.

The CurrencyShares Trusts are distributed by Guggenheim Funds Distributors, LLC. Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC (“Guggenheim”), which includes Security Investors, LLC (“SI”). Guggenheim Specialized Products, LLC (“GSP”), the Sponsor for the CurrencyShares Trusts, is a wholly owned subsidiary of SI. Guggenheim Funds Distributors, LLC, is affiliated with Guggenheim, SI and GSP.

Not FDIC Insured – No Bank Guarantee –May Lose Value.

TEMP 19119

1 Guggenheim Investments total asset figure is as of 12.31.2015. The assets include leverage of $12.0bn for assets under management and $0.5bn for assets for which we provide administrative services.  Guggenheim Investments represents the following affiliated investment management businesses: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Real Estate, LLC, Transparent Value Advisors, LLC, GS GAMMA Advisors, LLC, Guggenheim Partners Europe Limited and Guggenheim Partners India Management.

Media Contact Guggenheim Ivy McLemore 212.518.9859 Ivy.mclemore@guggenheimpartners.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 479

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 354

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 122

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 298

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 225

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 292

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 638

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Zenarate Achieves Remarkable Growth, Securing Top Technology Honors

Updated Category News Views 231

Zenarate's Impressive Achievement in the Fast-Growing Tech Sector Zenarate, a leading platform focused on enhancing human and AI agent performance, has made waves in the tech industry with its exceptional ranking. With a remarkable growth of 496%, Zenarate has earned the prestigious recognition as the 165th fastest-growing company on the Deloitte Technology Fast 500™...

Continue Reading
GitLab Inc. Investors Encouraged to Participate in Class Action

Updated Category News Views 64

Important Class Action Opportunity for GitLab Inc. Investors GitLab Inc. shareholders are facing a critical moment, with a significant class action opportunity emerging due to recent events. Robbins Geller Rudman & Dowd LLP has made a vital announcement urging investors who bought GitLab securities during specific dates to come forward. This class action lawsuit, known as...

Continue Reading
Transforming $1000 into Significant Wealth with EME Investment

Updated Category News Views 261

Transform Your Investment Journey with EMCOR Group Investing wisely is a journey that can lead to fruitful rewards, especially when considering the historical performance of a stock. EMCOR Group (EME) is a fine example, having shown impressive growth over the past 15 years. If one were to invest $1000 in EME back then, they would be pleasantly surprised by today's...

Continue Reading
Brown & Brown, Inc. Declares Regular Quarterly Dividend Payment

Updated Category News Views 199

Brown & Brown, Inc. Dividends: Commitment to Shareholders Brown & Brown, Inc. (NYSE: BRO), an established insurance brokerage firm, recently made headlines with the announcement of a quarterly cash dividend of $0.15 per share. This decision was made public by the company's board of directors, illustrating their ongoing commitment to delivering value to their shareholders....

Continue Reading
OCS Finalizes Landmark Acquisition of EMCOR UK for Growth

Updated Category News Views 251

OCS Completes Acquisition of EMCOR UK OCS has officially completed its acquisition of EMCOR UK, marking a significant milestone in the facilities management sector. This strategic move follows the rigorous UK regulatory process, enabling OCS to merge with one of the largest hard services-led businesses in the region. The integration is expected to leverage the extensive...

Continue Reading